Skip to content
healthcare.dev

imatinib mesylate

NDC 67184-0532, imatinib mesylate, tablet, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0532
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212135
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0532 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IMATINIB MESYLATE100 mg/1

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]

Package NDCNDC-11Package
67184-0532-16718405320190 TABLET in 1 BOTTLE (67184-0532-1)
67184-0532-267184053202500 TABLET in 1 BOTTLE (67184-0532-2)
67184-0532-36718405320330 BLISTER PACK in 1 CARTON (67184-0532-3) / 10 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/82eb01e0-8685-4f06-8a72-7663e8ded38f

Use it

Look up 67184-0532 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0532 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0532. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.